Evropska unija - slovenščina - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - zdravila za obstruktivne pljučne bolezni, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Evropska unija - slovenščina - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - zdravila za obstruktivne pljučne bolezni, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Evropska unija - slovenščina - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihidrat, glycopyrronium bromid - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Evropska unija - slovenščina - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihidrat, glycopyrronium - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - vzdrževalnega zdravljenja pri odraslih bolnikih z zmerno do hudo kronična obstruktivna pljučna bolezen (kopb), ki ni primerno obravnavana kombinacija inhalacijski kortikosteroidi in dolgotrajnim delovanjem beta2-agonist (učinkov na simptomi nadzor in preprečevanje poslabšanj glej oddelek 5.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

orion corporation - budezonid - prašek za inhaliranje, odmerjeni - budezonid 80 µg / 1 odmerek - formoterol in budezonid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

orion corporation - budezonid - prašek za inhaliranje - budezonid 80 µg / 1 odmerek - formoterol in budezonid

Evropska unija - slovenščina - EMA (European Medicines Agency)

glaxosmithkline trading services limited - flutikazon furoat, umeclidinium bromid, vilanterol trifenatat - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - elebrato ellipta je označen kot vzdrževalnega zdravljenja pri odraslih bolnikih z zmerno do hudo kronična obstruktivna pljučna bolezen (kopb), ki ni primerno obravnavana s kombinacijo inhalacijski kortikosteroidi in dolgotrajnim delovanjem β2-agonist.

Evropska unija - slovenščina - EMA (European Medicines Agency)

glaxosmithkline trading services - flutikazon furoat, umeclidinium bromid, vilanterol trifenatat - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - trelegy ellipta je označen kot vzdrževalnega zdravljenja pri odraslih bolnikih z zmerno do hudo kronična obstruktivna pljučna bolezen (kopb), ki ni primerno obravnavana s kombinacijo inhalacijski kortikosteroidi in dolgotrajnim delovanjem β2-agonist.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

altamedics d.o.o. - hidrokortizon - tableta - hidrokortizon 10 mg / 1 tableta - hidrokortizon

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited - indakaterol maleat - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - zdravilo hirobriz breezhaler je indicirano za vzdrževanje bronhodilatatorja pri obtoku zračnega toka pri odraslih bolnikih s kronično obstruktivno pljučno boleznijo.